Digital rendering of Arcalis' new manufacturing site in Minamisoma City, Japan.
Arcturus Therapeutics handed $115M from Japanese government to develop production site
San Diego-based RNA biotech Arcturus Therapeutics’ manufacturing operations in Japan have been given a financial boost from the local government.
Arcalis Co., Ltd., its production …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.